Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
23.6M
-
Shares change
-
+324K
-
Total reported value, excl. options
-
$678M
-
Value change
-
+$11.5M
-
Put/Call ratio
-
1.72
-
Number of buys
-
71
-
Number of sells
-
-62
-
Price
-
$28.68
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q2 2023
161 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q2 2023.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.6M shares
of 27.1M outstanding shares and own 87.09% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.78M shares), BlackRock Inc. (1.99M shares), STATE STREET CORP (1.98M shares), ARK Investment Management LLC (1.91M shares), VANGUARD GROUP INC (1.63M shares), Nikko Asset Management Americas, Inc. (1.4M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.4M shares), Woodline Partners LP (1.07M shares), FMR LLC (866K shares), and DIMENSIONAL FUND ADVISORS LP (695K shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.